Development progress status of treatment for epidermolysis bullosa
| Progress status | |
|---|---|
| United States | • Received Orphan drug designation from the US FDA. • Phase II Clinical trial completed • Establishing clinical development strategies |
*Related link
http://www.clinicaltrials.gov/ct2/show/NCT00311766?term=thymosin+beta+4&rank=5